NCT02676050 Visualising c-MET and Activated Neutrophils in Lung Cancer Status TERMINATED Phase EARLY_PHASE1
NCT02675842 Investigation of Cannabis for Pain and Inflammation in Lung Cancer Status WITHDRAWN Phase PHASE1
NCT02675829 Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02673021 MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) Status TERMINATED Phase NA
NCT02665078 Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules Status COMPLETED Phase N/A
NCT02664259 UTB-VBN-EBUS With or Without Fluoroscopy for the Diagnosis of PPLs Status COMPLETED Phase NA
NCT02664181 Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial Status COMPLETED Phase PHASE2
NCT02663817 DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy Status COMPLETED Phase NA
NCT02663492 Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients Status UNKNOWN Phase NA
NCT02652286 Pulmonary Artery Harmonic Ace+7 Energy Sealing in VATS Lobectomy Status COMPLETED Phase EARLY_PHASE1
NCT02651441 D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) Status UNKNOWN Phase PHASE1/PHASE2
NCT02648178 Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers Status COMPLETED Phase NA
NCT02646748 Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02644252 Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer Status TERMINATED Phase PHASE3
NCT02638090 Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02625168 Afatinib vs Erlotinib as 2nd TKI After Failure to 1st TKI and Chemotherapy for Metastatic NSCLC Status COMPLETED Phase PHASE2
NCT02622607 Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer Status UNKNOWN Phase PHASE3
NCT02616211 An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors Status COMPLETED Phase N/A